Live Breaking News & Updates on Glycocalyx Study

Stay updated with breaking news from Glycocalyx study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

BioRegenx Announces Cardiovascular Disease Studies Using Its Medical Testing Device GlycoCheck

BioRegenx, Inc. and its subsidiary Microvascular Health Solutions, LLC (MVHS), based in Alpine, Utah, announced that two peer-reviewed studies have been ....

United States , Robertm Long , Hans Vink , Microvascular Health , Circulation American Heart Association , Microvascular Health Solutions , Association Of Gestational Diabetes , Securities Exchange , Nulife Sciences Inc , Journal Of Cardiovascular Translational Research , Bioregenx Inc , Endothelial Glycocalyx Study , Glycocalyx Study , Gestational Diabetes , Subclinical Cardiovascular Disease , Endothelial Function , Chief Science Officer , Endothelial Glycocalyx Predicts Adverse Outcome , Subjects Without Overt Cardiovascular Disease , Year Follow Up Study , Cardiovascular Translational Research , Endothelial Function Testing , American Heart Association , Gestational Diabetes Mellitus , Endocalyx Pro , Nulife Sciences ,